Professional Documents
Culture Documents
Industrial Production of Aa by Coryneform Bacteria
Industrial Production of Aa by Coryneform Bacteria
www.elsevier.com/locate/jbiotec
Abstract
In the 1950s Corynebacterium glutamicum was found to be a very efficient producer of L-glutamic acid. Since this
time biotechnological processes with bacteria of the species Corynebacterium developed to be among the most
important in terms of tonnage and economical value. L-Glutamic acid and L-lysine are bulk products nowadays. LValine, L-isoleucine, L-threonine, L-aspartic acid and L-alanine are among other amino acids produced by
Corynebacteria . Applications range from feed to food and pharmaceutical products. The growing market for amino
acids produced with Corynebacteria led to significant improvements in bioprocess and downstream technology as well
as in molecular biology. During the last decade big efforts were made to increase the productivity and to decrease the
production costs. This review gives an overview of the world market for amino acids produced by Corynebacteria .
Significant improvements in bioprocess technology, i.e. repeated fed batch or continuous production are summarised.
Bioprocess technology itself was improved furthermore by application of more sophisticated feeding and automatisation strategies. Even though several amino acids developed towards commodities in the last decade, side aspects of the
production process like sterility or detection of contaminants still have increasing relevance. Finally one focus of this
review is on recent developments in downstream technology.
# 2003 Elsevier B.V. All rights reserved.
Keywords: Coryneform bacteria; Amino acids; Bioprocess; Downstream
1. Introduction
The recently finished deciphering of the Corynebacterium glutamicum genome by several amino acid producers marked a further milestone for
industrial use of this microorganism. The history
of the species Corynebacterium as amino acid
producer started in the 1950s when Dr Kinoshita
(T.
0168-1656/03/$ - see front matter # 2003 Elsevier B.V. All rights reserved.
doi:10.1016/S0168-1656(03)00149-4
156
2. Market overview
Current total annual worldwide consumption of
amino acids is estimated to be over 2 million tons.
The annual demand for amino acids like MSG
based flavour enhancers or feed additives comprised mainly of L-lysine, D,L-methionine and Lthreonine is estimated to be significantly higher
than 1 million tons each. The annual demand for
amino acids used in pharmaceutical products
mainly for intravenous and enteral nutrition is
15 000 tons (Kusumoto, 2001).
Around 1.5 million tons L-glutamic acid are
produced per year using coryneform bacteria.
MSG is used in food as a taste enhancer and
because of its own unique flavour called Umami
in Japanese. Prepared food usually contains 0.1 /
0.8% MSG but especially in east Asian dishes a
higher supplementation is common. Despite reports quoting some observers and experts that
MSG could be dangerous for health, a survey by
WHO and FAO showed that most food sweeteners
are safe for the health of humans. At the moment
the glutamic acid market is growing by about 6%
per year. Major producers of MSG are Ajinomoto,
Miwon, Kyowa-Hakko and Cheil-Jedang.
Compared with L-glutamic acid, L-lysine is used
almost completely as a feed additive. Traditional
feedstuffs like corn, wheat or barley are poor in
lysine. In order to increase feed efficiency, either Llysine rich crops like soybean meal or L-lysine is
added to these raw materials. Adding soybean
meal increases the protein level and supplies
additional non-limiting amino acids. The dosed
addition of L-lysine saves raw materials and
reduces nitrogen excretion.
Addition of 0.5% L-lysine increases feed quality
as much as adding approximately 20% soybean
meal. Because most of the other amino components of soybean meal are not used by the animals,
the amount of nitrogen excretion is increased
significantly. Using low protein diets supplemented with crystalline amino acids and applying
feeding strategies, which closely match animal
requirements, can help solve this problem.
In 2001, the world market for L-lysine was
550 000 tons with a growth rate of 7% per year.
Main producers are Ajinomoto, ADM, Kyowa
Hakko, Cheil Jedang, BASF and Degussa through
its Midwest Lysine joint venture with Cargill. LLysine is produced exclusively in bioprocesses
using coryneform bacteria.
Like L-lysine, the amino acid L-threonine is used
almost exclusively as a feed additive. Especially pig
and poultry diets have a high demand of Lthreonine. While i.e. corn germ meal contains
similar amounts of L-threonine and L-lysine,
soybean meal contains almost twice as much Llysine as L-threonine. The increase of L-threonine
concentration from 0.55 to 0.75% in a corn /
sorghum /peanut meal based diet for young broilers increases the breast meat deposition by more
than 15%.
In 2002, the L-threonine world market has a
volume of about 30 000 tons with an approximate
annual growth rate of 15%. Major producers are
157
158
4. Bioprocess technology
4.1. Standard bioprocesses for production of amino
acids
Bioprocesses for production of amino acids
were developed since the end of the 1950s. In the
beginning the technology served only a small
market but during the years the demand grew
and new applications were found. With the growing market the size of the plants and the bioreactors increased stepwise. Nowadays bioreactor sizes
from 50 to 500 m3 are standard in amino acid
production (depending on the product).
Before reaching the production reactor a few
other steps have to be carried out. Inocula
preparation is the first crucial step in most
bioprocesses. The purpose of this lab procedure
is to obtain a huge amount of stable inocula, which
could be used to run dozens of production batches
under the same defined conditions finally reaching
the same result or yield. Inocula have to be
process air increased the biomass yield and considerably decreased formation of organic acids in
L-lysine production with leucine and homoserine
auxotrophic C. glutamicum (Hadj-Sassi et al.,
1996). Oxygen availability was evaluated by several authors. Recently Shu and Liao (2002)
revealed the relevance of the oxygen transfer rate
coefficient (KLa) on L-phenylalanine production
with C. glutamicum . They showed that increased
oxygen transfer rates (OTR) increase L-phenylalanine productivity and yield (positively) up to 42%
reaching values of 0.37 g l 1 h1 and 14%,
respectively. Yao et al. (2001) showed for L-lysine
production with Brevibacterium lactofermentum
that dissolved oxygen concentrations influence
the process. Inhibition of high pO2 could occur
during the very early growth phase and depressive
effect of low oxygen availability was confined to
the rest of the process. These results suggest that
different stages of the bioprocess require different
pO2 levels. By adapting a pO2 profile the L-lysine
yield was increased from 0.300 to 0.343 g g1.
Whether these effects were due to changed pO2 or
pCO2 was not elucidated.
Process temperature can be changed depending
on the demands of the organism. Elevated temperatures are used to induce L-glutamic acid
production in certain strains (Gourdon and Lindley, 1999; Delaunay et al., 2002). Most textbooks
mention 30/34 8C as the optimum temperature for
cultivating coryneform bacteria. However, strains
with increased thermotolerance were described
recently (Kimura et al., 2002). Those strains are
sometimes preferred for production processes
because of the limited amount of cooling water
available at some production sites.
Standard bioreactors for production of amino
acids are equipped with simple Rushton turbines
or in combination with axial mixing systems.
Stirrer tip speed seems to be a smaller problem
with coryneform bacteria than with some other
biotechnologically relevant organisms. A possible
reason for this might be the thick cell wall
encircling the cell (Marienfeld et al., 1997). Gas
blending can be used to separate effects of
dissolved oxygen from negative influences of the
stirrer tip speed (Pollard et al., 2002). However,
like in all bioreactors, mixing is a problem
159
160
1.
2.
3.
4.
161
162
2.
Carbon or phosphate limited continuous cultures are favourable because they allow a tight
control of the process and reduce the risk of
contaminations. Koyoma et al. (1998) describe a
continuous process for production of L-glutamic
acid with Brevibacterium lactofermentum reaching
volumetric productivities of up to 8 g l 1 h 1 and
thus doubling productivities achieved with batch
processes. In 1989, Hirao et al. described a
continuous process for the production of L-lysine
(Hirao et al., 1989). They used a strain based on C.
glutamicum ATCC13032 resistant to S -(2-aminoethyl)-L-cysteine, rifampicin, streptomycin and
6-azauracil reaching productivities of 5.6 g l 1
h1 and a L-lysine /HCl yield on glucose of 0.40 g
g1. The process itself showed a stable L-lysine
production for more than 300 h. Considering a
preparation time of 10 h the fed batch process with
this strain reached a productivity of 1.72 g l 1 h1
(100 g l1 L-lysine /HCl in 48 h process time).
Under these constraints the continuous process
showed a more than 3-fold increase in productivity
compared with the standard fed batch process. In
parts this was achieved by optimisation of the
culture redox potential kinetics. A similar approach was used for L-lysine producing C. glutamicum by Kwong and Rao (1991, 1992) which
added dithiothreithole to optimise the redox
potential of an aerobic growing batch culture. By
this the redox potential was lowered and in parallel
amino acid production rate was increased significantly. de Hollander et al. (1997) described a Llysine bioprocess with coryneform bacteria under
carbon and phosphate double limitation. Compared with a carbon limited process the productivity was increased from 3.18 to 3.75 g l 1 h1 L-
lysine /HCl. Additionally the biomass specific Llysine formation was increased 2.8-fold and the
typical instability of the strains under continuous
conditions was reduced under double limitation.
Major drawbacks for continuous bioprocesses are
mainly the risk of the contaminations in the
culture and possible strain instabilities. Contamination risk is increased in continuous culture
because of additional flows into and from the
vessel. The medium is often sterilised through
continuous sterilisers which have a particular risk
of blockage (Gondorf, 2001) when used with some
salts and nutrient combinations. However, if a
severe contamination of the culture occurs it is
usually detected early enough to allow a save finish
of the bioprocess. The potential loss in these cases
is usually much smaller than the gain in productivity of the plant working in continuous mode.
Strain instabilities could be reduced by process
modifications as mentioned above. On the other
hand continuous lab cultures are used to select
mutants with changed properties, i.e. faster
growth. Azuma et al. (1988) and Azuma and
Nakanishi (1988) describe these effects in continuous bioprocesses for producing L-arginine with
Corynebacterium acetoacidophilum .
Several groups tried to improve continuous
bioprocesses by separating the process into two
or more bioreactors. Usually the growth phase
takes place in a first bioreactor, while production
phases take place in another one. This so called
cascade bioprocess allows to run each phase of
growth under optimised conditions. In processes
with separated growth and production phases as
described for many amino acid producers this
procedure seems to be beneficial. In production
plants such a process modification allows to
include seed fermenters in the production process.
High growth rates lead to low residence times
which are often suitable for these usually smaller
bioreactors. Production phases with their small
growth rates could then be transferred into the
much bigger main reactors increasing the plant
productivity by the volume of the seed fermenters
(Emde, 1997).
Recent developments of repeated fed batch and
continuous processes indicate the tremendous
163
164
165
166
167
168
Fig. 2. Comparison of downstream processes for production of L-lysine/HCl using ion exchange (Oka, 1999), L-threonine using
crystallisation steps (Ohtani et al., 1987) and a biomass containing L-lysine by spray granulation (Hofler et al., 1997).
5. Outlook
Applications of amino acids either in food and
pharmaceuticals or in animal feed nutrition is
Acknowledgements
I would like to thank K. Huthmacher and W.
Pfefferle for continuous support. Furthermore I
am grateful to M. Rieping, B. Bathe, R. Kelle and
G. Thierbach for helpful discussions and a lot of
suggestions. Furthermore I would like to thank J.
Rolando and G. Himmel for many helpful comments.
References
Akesson, M., Hagander, P., Axelsson, J.P., 2001. Avoiding
acetate accumulation in Escherichia coli cultures using
feedback control of glucose feeding. Biotechnol. Bioeng.
73, 223 /230.
Albert, S., Kinley, R.D., 2001. Multivariate statistical monitoring of batch processes: an industrial case study of fermentation supervision. Trends Biotechnol. 19, 53 /62.
Amanullah, A., Baba, A., McFarlane, C.M., Emery, A.N.,
Nienow, A.W., 1993. In: Nienow, A.W. (Ed.), Bioreactor
and Bioprocess Fluid Dynamics. Mechanical Engineering
Publications, London, p. 381.
Amanullah, A., McFarlane, C.M., Emery, C.M., Nienow,
A.W., 2001. Scale-down model to simulate spatial pH
variations in large-scale bioreactors. Biotechnol. Bioeng.
73, 390 /399.
Arnold, S., Becker, T., Delgado, A., Emde, F., Enenkel, A.,
2002. Optimizing high strength acetic acid bioprocess by
169
170
171
Oka, T., 1999. Amino acids, production processes. In: Flickinger, M.C., Drew, S.W. (Eds.), Encyclopedia of Bioprocess
Technology: Fermentation, Biocatalysis, and Bioseparation.
Wiley, London, p. 89.
Okamoto, K., Ikeda, M., 2000. Development of an industrial
stable process for L-threonine fermentation by an Lmethionine-auxotrophic mutant of Escherichia coli . J.
Biosci. Bioeng. 89, 87 /89.
Osterberg, T., Wadsten, T., 1999. Physical state of L-histidine
after freeze-drying and long-term storage. Eur. J. Pharm.
Sci. 8, 301 /308.
Pfefferle, W., Lotter, H., Friedrich, H., Degener, W., 1993.
Process for the fermentative production of amino acids.
European patent 532,867.
Pfefferle, W., Mockel, B., Bathe, B., Marx, A., 2003. Biotechnological manufacture of lysine. In: Scheper, T. (Ed.),
Advances in Biochemical Engineering, vol. 79. Springer,
Berlin, pp. 59 /112.
Pham, C.B., 1994. Preparation of L-lysine by repeated fed batch
fermentation using mutant strains of auxotrophic homoserine in fermentation medium containing coconut water
enriched by sugar or sugar substrate. Patent Philippines PH
27,995.
Pham, C.B., Matsumura, M., Kataoka, H., 1995. Microb. Util.
Renewable Resour. 9, 539.
Pollard, D.J., Kirschner, T.F., Hernandez, D., Hunt, G.,
Olewinski, R., Salmon, P.M., 2002. Pilot-scale process
sensitivity studies for the scaleup of a fungal fermentation
for the production of pneumocandins. Biotechnol. Bioeng.
78, 270 /279.
Radmacher, E., Vaitsikova, A., Burger, U., Krumbach, K.,
Sahm, H., Eggeling, L., 2002. Linking central metabolism
with increased pathway flux: L-Valine accumulation by
Corynebacterium glutamicum . Appl. Environ. Microbiol.
68, 2246 /2250.
Research disclosure, 2000. Research disclosure 431, 427.
Reuss, M., Schmalzriedt, S., Jenne, M., 2000. Application of
Computational Fluiddynamics (CFD) to Modelling Stirred
Tank Bioreactors. In: Schugerl, K., Bellgardt, K.-H. (Eds.),
Bioreaction Engineering. Springer, Berlin.
Roubos, J.A., van Straten, G., van Boxtel, A.J.B., 1999. An
evolutionary strategy for fed-batch bioreactor optimization;
concepts and performance. J. Biotechnol. 67, 173 /187.
Ruebenhagen, R., Morbach, S., Kraemer, R., 2001. The
osmoreactive betaine carrier BetP from Corynebacterium
glutamicum is a sensor for cytoplasmic K . EMBO J. 20,
5412 /5420.
Sahm, H., Eggeling, L., Eikmanns, B., Kramer, R., 1996.
Construction of L-lysine-, L-threonine-, and L-isoleucineoverproducing strains of Corynebacterium glutamicum .
Ann. New York Acad. Sci. 782, 25 /39.
Sanders, M.E., 1993. Bacteriophages in industrial fermentations. In: Webster, R.G., Granoff, A. (Eds.), Encyclopedia
of Virology. Academic Press, London, pp. 117 /121.
Schendel, F.J., Bremmon, C.E., Flickinger, M.C., Guettler, M.,
Hanson, R.S., 1990. L-lysine production at 50 8C by
172
mutants of a newly isolated and characterized methylotrophic Bacillus sp. Appl. Environ. Microbiol. 56, 963 /970.
Schilling, B.M., Pfefferle, W., Bachmann, B., Leuchtenberger,
W., Deckwer, W.-D., 1999. A special reactor design for
investigations of mixing time effects in a scaled-down
industrial L-lysine fed-batch fermentation process. Biotechnol. Bioeng. 64, 599 /606.
Schmalzriedt, S., Reuss, M., 1999. Einsatz von CFD zur
Analyse biotechnischer Stoffumsetzungen in ein- und zweiphasig durchstromten Ruhrkesselreaktoren. Chem.-Ing.Tech. 71 (9), 954 /955.
Schweder, T., Kruger, E., Xu, B., Jurgen, B., Blomsten, G.,
Enfors, S.O., Hecker, M., 1999. Monitoring of genes that
respond to process-related stress in large-scale bioprocesses.
Biotechnol. Bioeng. 65, 151 /159.
Shimizu, H., Takiguchi, N., Tanaka, H., Shioya, S., 1999. A
maximum production strategy of lysine based on a simplified model derived from a metabolic reaction network.
Metabol. Eng. 1, 299 /308.
Shioya, S., Shimizu, H., Takiguchi, N., 1999. In: Lee, S.Y.,
Papoutsakis, E.T. (Eds.), Metabolic Engineering. Marcel
Dekker, New York, p. 227.
Shu, C., Liao, C., 2002. Optimization of L-phenylalanine
production of Corynebacterium glutamicum under product
feedback inhibition by elevated oxygen transfer rate.
Biotechnol. Bioeng. 77, 131 /141.
Stahl-Wernersson, E., Tragardh, C., 1999. Scale-up of Rushton
turbine-agitated tanks. Chem. Eng. Sci. 54, 4245 /4256.
Takiguchi, N., Shimizu, H., Shioya, S., 1997. An on-line
physiological state recognition system for the lysine fermen-